Catamaran (Nasdaq:CTRX) hit a new 52-week high Tuesday as it is currently trading at $57.59, above its previous 52-week high of $57.40 with 327,557 shares traded as of 11:11 a.m. ET. Average volume has been 1.5 million shares over the past 30 days.
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- Catamaran (Nasdaq: CTRX) hit a new 52-week high Tuesday as it is currently trading at $57.59, above its previous 52-week high of $57.40 with 327,557 shares traded as of 11:11 a.m. ET. Average volume has been 1.5 million shares over the past 30 days. Catamaran has a market cap of $11.77 billion and is part of the technology sector and computer software & services industry. Shares are up 21.4% year to date as of the close of trading on Monday. Catamaran Corporation provides pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefits management industry in North America. The company operates in two segments: PBM and HCIT. The company has a P/E ratio of 81.7, above the S&P 500 P/E ratio of 17.7.
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
TheStreet Ratings rates Catamaran as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, compelling growth in net income and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full Catamaran Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center. Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100% See his top picks for 14-days FREE.